Why the study?
Does a single measurement of NT-proBNP predict mortality better than LVEF, VO2, or HFSS in patients with advanced CHF?
Does a single measurement of NT-proBNP predict mortality better than LVEF, VO2, or HFSS in patients with advanced CHF?
A single NT-proBNP measurement is a superior prognostic marker for mortality in advanced heart failure compared to traditional metrics like LVEF, VO2, and HFSS.
Answers are grounded in this paper and cite their sources.
May better stratify mortality risk in advanced HF than LVEF, VO2, or HFSS; hypothesis-generating and requires prospective validation before practice change.
A single measurement of NT-proBNP in patients with advanced CHF, can help to identify patients at highest risk of death, and is a better prognostic marker than the LVEF, VO2 or HFSS.
No takes yet. Share an insight, caveat, or question.
R Gardner (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: